Search Result "Imatinib-d8."
Measurement of Sediment (MESED) and LC-MS-MS for Cellular Kinetics Studies of STI-571(Imatinib, Gleevec® , Glivec®) in Cells with Different Pgp- 170 Expression
Journal: Current Analytical Chemistry
Volume: 1 Issue: 2 Year: 2005 Page: 121-127
Author(s): Hans Prenen, Gunther Guetens, Allan T. van Oosterom, Gert De Boeck, Martin S. Highley, Ernst A. de Bruijn
Simultaneous Determination of Imatinib and N-Desmethyl Imatinib in Rat Plasma and Tissues Using LC-MS/MS
Journal: Current Pharmaceutical Analysis
Volume: 15 Issue: 2 Year: 2019 Page: 121-129
Author(s): Zhi Rao,Bo-xia Li,Yong-Wen Jin,Wen-Kou,Yan-rong Ma,Guo-qiang Zhang,Fan Zhang,Yan Zhou,Xin-an Wu
A Concise Review on Analytical Methods for Determination of Nilotinib
Journal: Current Analytical Chemistry
Volume: 19 Issue: 7 Year: 2023 Page: 513-530
Author(s):
Cancer Stem Cells and Therapeutic Perspectives
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 6 Year: 2006 Page: 603-607
Author(s): E. Galmozzi, F. Facchetti, CAM L. Porta
Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 982-1000
Author(s): Vincenzo Emanuele Chiuri, Nicola Silvestris, Andrea Tinelli, Vito Lorusso
Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 3 Year: 2006 Page: 207-227
Author(s): Christian Kurzeder, Georg Sauer, Helmut Deissler
Current Status of Clinical Trials for Glioblastoma
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 3 Year: 2006 Page: 265-281
Author(s): Michael L. Salgaller, Linda M. Liau
Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 3 Year: 2007 Page: 174-193
Author(s): Enrico Mihich
Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 2 Issue: 3 Year: 2003 Page: 206-215
Author(s): Yves St-Pierre, Celine Van Themsche, Pierre-Olivier Esteve
Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 553-563
Author(s): Hironori Harada, Yuka Harada, Akiro Kimura